Senate · 119th Congress, session 2 · roll call 103 · April 23, 2026

On the Amendment S.Amdt. 5336 to S.Con.Res. 33 (No short title on file)

Wyden Amdt. No. 5336

Amendment: S.Amdt. 5336: To establish a deficit-neutral reserve fund relating to requiring the Comptroller General of the United States to conduct a study related to economic consequences of private or confidential drug pricing agreements struck by any Federal department, agency, or office with any pharmaceutical manufacturer.

48-50 failed
2crossed party lines
30news score
D 44–0 · R 2–50 · I 2–0
Why this vote scores 30:
  • decided by 2 votes (48-50)
  • measure failed on the floor

Crossed party lines

MemberPartyStateVoted
Dan Sullivan R AK Yea
Susan M. Collins R ME Yea

Every member's vote

✓ Yes (48)

✕ No (50)

— Not voting (2)

Source: official record